COVID-19: Karnataka initiates Phase I clinical trials to use Convalescent Plasma Therapy

Karnataka on Saturday initiated phase one of clinical trials to use  Convalescent Plasma rapy to treat severe COVID-19 infected patients.

Taking to Twitter, Karnataka Health Minister B Sriramulu stated BMC Victoria hospital has taken first step to start rapy. He furr wished doctors of hospital a great success. According to him, it is a "torchbearer" in fight against Coronavirus. 

Currently, in Karnataka, re are a total of 474 cases of Coronavirus, out of which, 152 have been recovered, while 18 people have succumbed to infection. 

Read: This Rickshaw-driver's Covid invation may land him a job at Anand Mahindra's companies

About Plasma rapy 

antibodies created to fight infection remain in a person's blood even after his/her recovery from vel coronavirus. If such an individual donates blood, plasma which has a high concentration of antibodies can be transfused to a COVID-19 patient. This could help boost immune system of latter.

Read: Karnataka medical stores to maintain record of people buying drugs for flu-like symptoms

COVID-19 cases in India 

According to latest update from Ministry of Health & Family Welfare, number of total Coronavirus cases in country has climbed to 24,506, including 18,668 active cases. While 775 deaths have been reported overall, around 5,063 people have been cured/discharged/migrated. Meanwhile, Maharashtra and Delhi have highest number of cases in country. 

Read: 27 million daily for 100 years?: Ivanka schooled for saying US will plant 1 TRILLION trees

Read: India's COVID-19 cases cross 24,500; Death toll at 775 and 5,063 recoveries thus far